Global health governance, R&D and global health, Nutrition and food safety, Health emergency
1. Development and Implementation of a Precision Intervention System forVaccine Hesitancy Utilizing Generative Artificial Intelligence, China National Natural Science Foundation, 2026-2029, PI
2. Optimizing the Effectiveness of Vaccine Regulation through Research on Vaccine Policy and Pathways from the Whole Life-cycle Perspective, China National Natural Science Foundation/ Bill & Melinda Gates Foundation, PI
3. Innovation Mode of R&D of Core Products for Emerging Infectious Diseases in China under the Perspective of Innovation Driving, China National Natural Science Foundation, 2021-2024, PI
4. Research on China’s Pathways and International Cooperation Mechanisms in Global Health Governance under the Belt and Road Initiative, The National High-level Talent Special Support Program (Ten Thousand Talents Program) Young Top-notch Talent, 2023-2025, PI
5. Documenting China's Nutrition Improvement Program for Children in Poverty Areas, The United Nations Children's Fund, 2020-2022, PI
6. Current Status and Challenges of the Covid-19 Outbreak Response for Public Health Emergency Operating Centers in Africa, World Health Organization Regional Office for Africa, 2021, PI
7. Public Health Governance Paths and Collaboration among BRICS Countries, China Association for Science and Technology Young Talent Program, 2023, PI
8. Promoting the Development and Accessibility of Combination Vaccines for Children in China, China Medical Board, 2021-2024, PI
9. China's Participation in Strategies for Promoting Global Pharmaceutical Product Innovation, The Soft Science Research Program of State Intellectual Property Office, 2020-2021, PI
10. Study on the Current Status and Development Strategies of International Health Cooperation under the Belt and Road Initiative in Beijing, Key Project of the Beijing Municipal Health Commission, 2021-2023, PI
1. Junsheng Huo, Yangmu Huang, Jing Sun, Jian Huang, Jingya Dong, Yinuo Sun, Xing Lin Feng. Malnutrition in infants aged 6-23 months in China's poorest rural counties from 2016 to 2021: cross sectional study. BMJ, 2024, 387, e079499.
2. Yinuo Sun, Jiyan Ma, Jingya Dong, Yiwu Gu, Myeong Soo Lee, Lin Ang, Yuming Liu, Yangmu Huang*. International collaborative research and development (R&D) on traditional medicine and its contextual factors: a cross-sectional analysis from 1996 to 2022. Journal of Global Health. 2026, 16:04029.
3. Zhiyong Zou, Guangqi Liu, Simon I Hay, Saurav Basu, Uzma Iqbal Belgaumi, Arkadeep Dhali, Sameer Dhingra, Ginenus Fekadu, Mahaveer Golechha, Nitin Joseph, Kewal Krishan, Francisco Rogerlândio Martins-Melo, Sumaira Mubarik, Osaretin Christabel Okonji, Mahesh P A, Priya Rathi, Ranjitha S Shetty, Paramdeep Singh, Surjit Singh, Pugazhenthan Thangaraju, Ziyue Wang, Mikhail Sergeevich Zastrozhin, Christopher J L Murray, Hmwe Hmwe Kyu, Yangmu Huang*. Time trends in tuberculosis mortality across the BRICS: an age-period-cohort analysis for the GBD 2019. EClinicalMedicine, 2022, 53:101646.
4. Zhicheng Wang, Rizhen Wang, Qianyi Xi, Yangmu Huang*. Forging medical treatment partnerships to enhance PHC clinical trials in China. Lancet Global Health. 2025, 13(7):e1172.
5. Jiyan Ma, Yang Yang, Yangmu Huang*. Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990-2022. Emerging infectious diseases, 2025, 31(1), 14–21.
6. Yang Yang, Lewis Husain, Yangmu Huang*. China's position and competitiveness in the global antibiotic value chain: implications for global health. Globalization and health, 2024, 20(1), 87.
7. Jiyan Ma, Chao Li, Yuxuan Cui, Lubin Xu, Nuo Chen, Rizhen Wang, Xiaoran Gao, Zuokun Liu, Yangmu Huang*. Preparing the developing world for the next pandemic: Evidence from China's R&D blueprint for emerging infectious diseases. Journal of infection and public health, 2024, 17(10), 102538.
8. Yuan Dang, Lin Wang, Yuming Liu, Boyan Wang, Huiwen Deng, Can Ye, Chunping Wang, Yangmu Huang*. Differences in PCV13 Recommendation Practices between Pediatric Care Providers and Primary Care Providers in China: A Cross-Sectional Survey of Behavior and Social Drivers. Vaccines, 2024, 12(9), 1082.
9. Yangmu Huang*, Yang Yang, Guangqi Liu, Ming Xu. New clinical application prospects of artemisinin and its derivatives: a scoping review. Infectious Disease of Poverty, 2023, 12(1):115.
10. Chao Li, Jingyi Chen, Yangmu Huang*. Challenges and opportunities for China entering global research and development for emerging infectious diseases: a case study of China’s Ebola related research and development. Infectious Diseases of Poverty, 2020,9(27).